Den hæmatologiske toksicitet for ovariecancerpatienter er mindre svær end for AIDS- KS- gruppen (se afsnittet for patienter med ovariecancer ovenfor).
The haematological toxicity for ovarian cancer patients is less severe than in the AIDS-KS setting (see section for ovarian cancer patients above).